Details for 2017804304

Up to date per 01.04.2026

Actions

Title / Product Name

DOSIS UND DOSIERSCHEMA FÜR INHIBITOREN DER HDM2-P53-INTERAKTION

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017804304

EP Publication Number

3541387

E-Number

1383910

Language

PCT Number

IB17057097

Publication Date

25.09.2019 A

21.04.2021 B1

Registration Date

21.04.2021

AT Publication Date

15.05.2021

Application Date

14.11.2017

Registration Number

Priorities

15.11.2016

201662422144 P

31.03.2017

201762479391 P

IPC

A61K 31/496 20060101AFI20200526BHEP

Maximum Duration of Protection

14.11.2037

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

FERRETTI, Stephanec/o Novartis Pharma AG Novartis Institutes for BioMedical Research Klybeckstrasse 141 Postfach 4002 BaselCH

GUERREIRO, Nelsonc/o Novartis Pharma AG Novartis Institutes for BioMedical Research Fabrikstrasse 2 4056 BaselCH

JEAY, Sebastienc/o Novartis Pharma AG Werk Klybeck Postfach 4002 BaselCH

JULLION, Astridc/o Novartis Pharma AG Forum 1 4056 BaselCH

MEILLE, Christophec/o Novartis Pharma AG Novartis Institutes for BioMedical Research Fabrikstrasse 2 4056 BaselCH

WUERTHNER, Jensc/o Novartis Pharma AG Novartis Institutes for BioMedical Research Postfach 4002 BaselCH